268 related articles for article (PubMed ID: 15572272)
1. Actometry and Barnes Akathisia Rating Scale in neuroleptic-induced akathisia.
Janno S; Holi MM; Tuisku K; Wahlbeck K
Eur Neuropsychopharmacol; 2005 Jan; 15(1):39-41. PubMed ID: 15572272
[TBL] [Abstract][Full Text] [Related]
2. Akathisia and pseudoakathisia: clinical observations and accelerometric recordings.
Rapoport A; Stein D; Grinshpoon A; Elizur A
J Clin Psychiatry; 1994 Nov; 55(11):473-7. PubMed ID: 7989279
[TBL] [Abstract][Full Text] [Related]
3. Measuring neuroleptic-induced akathisia by three-channel actometry.
Tuisku K; Lauerma H; Holi M; Markkula J; Rimon R
Schizophr Res; 1999 Nov; 40(2):105-10. PubMed ID: 10593450
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of intramuscular biperiden in acute akathisia: a double-blind, randomized, placebo-controlled study.
Baskak B; Atbasoglu EC; Ozguven HD; Saka MC; Gogus AK
J Clin Psychopharmacol; 2007 Jun; 27(3):289-94. PubMed ID: 17502777
[TBL] [Abstract][Full Text] [Related]
5. [Subjective experiences of patients with acute neuroleptic-induced akathisia].
Gruber O; Northoff G; Pflug B
Fortschr Neurol Psychiatr; 1998 Dec; 66(12):531-8. PubMed ID: 9922925
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic-induced acute and chronic akathisia: a clinical comparison.
Kim JH; Jin YH; Kang UG; Ahn YM; Ha KS; Kim YS
Mov Disord; 2005 Dec; 20(12):1667-70. PubMed ID: 16078203
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of akathisia in patients receiving stable doses of clozapine.
Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J
J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
[TBL] [Abstract][Full Text] [Related]
8. Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study.
Lerner V; Bergman J; Statsenko N; Miodownik C
J Clin Psychiatry; 2004 Nov; 65(11):1550-4. PubMed ID: 15554771
[TBL] [Abstract][Full Text] [Related]
9. Antisocial violent offenders with attention deficit hyperactivity disorder demonstrate akathisia-like hyperactivity in three-channel actometry.
Tuisku K; Virkkunen M; Holi M; Lauerma H; Naukkarinen H; Rimon R; Wahlbeck K
J Neuropsychiatry Clin Neurosci; 2003; 15(2):194-9. PubMed ID: 12724461
[TBL] [Abstract][Full Text] [Related]
10. Periodic limb movement disorder in neuroleptic-induced akathisia.
Nishimatsu O; Horiguchi J; Inami Y; Sukegawa T; Sasaki A
Kobe J Med Sci; 1997 Oct; 43(5):169-77. PubMed ID: 9642972
[TBL] [Abstract][Full Text] [Related]
11. [Neuroleptic-induced dysphoric response in non-schizophrenic patients].
Berardi D; Zanfini R; Alessi S; Giannelli A; Ferrari G
Minerva Psichiatr; 1993 Jun; 34(2):125-33. PubMed ID: 8105358
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study.
Poyurovsky M; Epshtein S; Fuchs C; Schneidman M; Weizman R; Weizman A
J Clin Psychopharmacol; 2003 Jun; 23(3):305-8. PubMed ID: 12826992
[TBL] [Abstract][Full Text] [Related]
13. A polysomnographic study on periodic limb movements in patients with restless legs syndrome and neuroleptic-induced akathisia.
Inami Y; Horiguchi J; Nishimatsu O; Sasaki A; Sukegawa T; Katagiri H; Yamawaki S
Hiroshima J Med Sci; 1997 Dec; 46(4):133-41. PubMed ID: 9538563
[TBL] [Abstract][Full Text] [Related]
14. Beta 2-receptor density on mononuclear blood cells in patients suffering from neuroleptic-induced akathisia (NIA).
Botschev C; Bondy B; Hofmann M; Kircher T; Müller-Spahn F
Biol Psychiatry; 1996 Aug; 40(3):203-7. PubMed ID: 8830953
[TBL] [Abstract][Full Text] [Related]
15. Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study.
Stryjer R; Rosenzcwaig S; Bar F; Ulman AM; Weizman A; Spivak B
Clin Neuropharmacol; 2010; 33(5):219-22. PubMed ID: 20838215
[TBL] [Abstract][Full Text] [Related]
16. The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study.
Sivrioglu EY; Kirli S; Sipahioglu D; Gursoy B; Sarandöl E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1493-9. PubMed ID: 17688987
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effect of low-dose mirtazapine in acute aripiprazole-induced akathisia.
Poyurovsky M; Bergman J; Pashinian A; Weizman A
Int Clin Psychopharmacol; 2014 Sep; 29(5):296-8. PubMed ID: 24667488
[TBL] [Abstract][Full Text] [Related]
18. Cocaine is a major risk factor for antipsychotic induced akathisia, parkinsonism and dyskinesia.
Maat A; Fouwels A; de Haan L
Psychopharmacol Bull; 2008; 41(3):5-10. PubMed ID: 18779773
[TBL] [Abstract][Full Text] [Related]
19. Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia.
Poyurovsky M; Nave R; Epstein R; Tzischinsky O; Schneidman M; Barnes TR; Weizman A; Lavie P
Eur Neuropsychopharmacol; 2000 May; 10(3):171-6. PubMed ID: 10793319
[TBL] [Abstract][Full Text] [Related]
20. Case study of neuroleptic-induced akathisia: important implications for individuals with mental retardation.
Gross EJ; Hull HG; Lytton GJ; Hill JA; Piersel WC
Am J Ment Retard; 1993 Jul; 98(1):156-64. PubMed ID: 8103997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
